Literature DB >> 8218698

Mycobacterium simiae infection in Israeli patients with AIDS.

D Huminer1, S Dux, Z Samra, L Kaufman, A Lavy, C S Block, S D Pitlik.   

Abstract

Mycobacterium simiae is an environmental organism that has rarely been associated with human disease. In Israel M. simiae is frequently isolated from clinical specimens, and it usually colonizes damaged lungs. Until now, only two cases of AIDS patients with M. simiae infection have been reported, and these patients were coinfected with Mycobacterium avium complex. Two Israeli patients with AIDS complicating hemophilia developed prolonged fever that was unresponsive to therapy with broad-spectrum antibiotics. One of them had cavitary pulmonary infiltrates. M. simiae was isolated from blood in both cases and from sputum and bone marrow in one case. The identity of the mycobacterium was confirmed at three reference laboratories. Both patients died of the infection. Thus, the possibility of M. simiae infection should be considered for AIDS patients who live in areas where this mycobacterium is prevalent.

Entities:  

Mesh:

Year:  1993        PMID: 8218698     DOI: 10.1093/clinids/17.3.508

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  11 in total

1.  Lesser known mycobacteria.

Authors:  B Watt
Journal:  J Clin Pathol       Date:  1995-08       Impact factor: 3.411

2.  A molecular epidemiological study of Mycobacterium simiae isolated from AIDS patients in Guadeloupe.

Authors:  E Legrand; A Devallois; L Horgen; N Rastogi
Journal:  J Clin Microbiol       Date:  2000-08       Impact factor: 5.948

3.  Development and application of multiprobe real-time PCR method targeting the hsp65 gene for differentiation of Mycobacterium species from isolates and sputum specimens.

Authors:  Kijeong Kim; Hyungki Lee; Mi-Kyung Lee; Seoung-Ae Lee; Tae-Sun Shim; Seong Yong Lim; Won-Jung Koh; Jae-Joon Yim; Bazarragchaa Munkhtsetseg; Wonyong Kim; Sang-In Chung; Yoon-Hoh Kook; Bum-Joon Kim
Journal:  J Clin Microbiol       Date:  2010-07-14       Impact factor: 5.948

4.  Activities of clarithromycin, ofloxacin, and clarithromycin plus ethambutol against Mycobacterium simiae in murine model of disseminated infection.

Authors:  G Valero; F Moreno; J R Graybill
Journal:  Antimicrob Agents Chemother       Date:  1994-11       Impact factor: 5.191

5.  Differentiation of Mycobacterium genavense and Mycobacterium simiae by automated mycolic acid analysis with high-performance liquid chromatography.

Authors:  D Ritter; L D Carlson; B K Logan; L S Ramos; J O Kilburn; M B Coyle
Journal:  J Clin Microbiol       Date:  1996-08       Impact factor: 5.948

6.  Mycobacterium simiae disseminated infection in a patient with acquired immunodeficiency syndrome.

Authors:  B Vandercam; J Gala; B Vandeweghe; J Degraux; G Wauters; L Larsson; A Bourlond; F Portaels
Journal:  Infection       Date:  1996 Jan-Feb       Impact factor: 3.553

Review 7.  Other HIV-associated pneumonias.

Authors:  Jakrapun Pupaibool; Andrew H Limper
Journal:  Clin Chest Med       Date:  2013-04-08       Impact factor: 2.878

8.  Pulmonary Mycobacterium simiae infection: comparison with pulmonary tuberculosis.

Authors:  C Maoz; D Shitrit; Z Samra; N Peled; L Kaufman; M R Kramer; J Bishara
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-05-17       Impact factor: 3.267

9.  Refractory bacteremia and osteomyelitis resulting in fatal bacteremic pneumonia with multiorgan failure caused by Mycobacterium simiae in a non-human immunodeficiency Virus-Infected Adult.

Authors:  Kuei-Pin Chung; Tzu-Hsiu Tsai; Yu-Tsung Huang; Po-Ren Hsueh
Journal:  J Clin Microbiol       Date:  2009-09-02       Impact factor: 5.948

10.  Multicenter cross-sectional study of nontuberculous mycobacterial infections among cystic fibrosis patients, Israel.

Authors:  Isaac Levy; Galia Grisaru-Soen; Liat Lerner-Geva; Eitan Kerem; Hana Blau; Lea Bentur; Micha Aviram; Joseph Rivlin; Elie Picard; Anita Lavy; Yakov Yahav; Galia Rahav
Journal:  Emerg Infect Dis       Date:  2008-03       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.